{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:53:23Z","timestamp":1768568003370,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/s1542-3565(04)00457-4","type":"journal-article","created":{"date-parts":[[2005,5,10]],"date-time":"2005-05-10T17:49:36Z","timestamp":1115747376000},"page":"1107-1115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":345,"title":["A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis"],"prefix":"10.1016","volume":"2","author":[{"given":"Arun J.","family":"Sanyal","sequence":"first","affiliation":[]},{"given":"Pouneh S.","family":"Mofrad","sequence":"additional","affiliation":[]},{"given":"Melissa J.","family":"Contos","sequence":"additional","affiliation":[]},{"given":"Carol","family":"Sargeant","sequence":"additional","affiliation":[]},{"given":"Velimir A.","family":"Luketic","sequence":"additional","affiliation":[]},{"given":"Richard K.","family":"Sterling","sequence":"additional","affiliation":[]},{"given":"R. Todd","family":"Stravitz","sequence":"additional","affiliation":[]},{"given":"Mitchell L.","family":"Shiffman","sequence":"additional","affiliation":[]},{"given":"John","family":"Clore","sequence":"additional","affiliation":[]},{"given":"Alan S.","family":"Mills","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1542-3565(04)00457-4_bib1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S1542-3565(04)00457-4_bib2","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/S1542-3565(04)00457-4_bib3","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","article-title":"The natural history of nonalcoholic fatty liver disease","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S1542-3565(04)00457-4_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/S1542-3565(04)00457-4_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/S1542-3565(04)00457-4_bib6","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/S1542-3565(04)00457-4_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/rp.59.1.207","article-title":"Obesity, insulin resistance, and cardiovascular disease","volume":"59","author":"Reaven","year":"2004","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/S1542-3565(04)00457-4_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/S1542-3565(04)00457-4_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11883-003-0007-0","article-title":"The insulin resistance syndrome","volume":"5","author":"Reaven","year":"2003","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/S1542-3565(04)00457-4_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1262-3636(07)70061-7","article-title":"Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease","volume":"29","author":"Diraison","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/S1542-3565(04)00457-4_bib11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2337\/diabetes.50.6.1389","article-title":"Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats","volume":"50","author":"Turcotte","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/S1542-3565(04)00457-4_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(02)00331-8","article-title":"Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease","volume":"38","author":"Sumida","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/S1542-3565(04)00457-4_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1582-4934.2002.tb00518.x","article-title":"Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet","volume":"6","author":"Oliveira","year":"2002","journal-title":"J Cell Mol Med"},{"key":"10.1016\/S1542-3565(04)00457-4_bib14","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/archinte.158.17.1855","article-title":"Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults","volume":"158","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/S1542-3565(04)00457-4_bib15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0022-3476(00)05040-X","article-title":"Vitamin E treatment of nonalcoholic steatohepatitis in children","volume":"136","author":"Lavine","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/S1542-3565(04)00457-4_bib16","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0024-3205(98)00482-2","article-title":"Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats","volume":"63","author":"Fujiwara","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/S1542-3565(04)00457-4_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI111938","article-title":"Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus","volume":"76","author":"DeFronzo","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/S1542-3565(04)00457-4_bib18","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S1542-3565(04)00457-4_bib19","first-page":"E214","article-title":"Glucose clamp technique","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/S1542-3565(04)00457-4_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jappl.1983.55.2.628","article-title":"Calculation of substrate oxidation rates in vivo from gaseous exchange","volume":"55","author":"Frayn","year":"1983","journal-title":"J Appl Physiol"},{"key":"10.1016\/S1542-3565(04)00457-4_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/dmg024","article-title":"Obesity and reproductive disorders in women","volume":"9","author":"Pasquali","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S1542-3565(04)00457-4_bib22","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","volume":"3","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S1542-3565(04)00457-4_bib23","first-page":"1008","article-title":"Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/S1542-3565(04)00457-4_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.20012","article-title":"A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis","volume":"39","author":"Promrat","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/S1542-3565(04)00457-4_bib25","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/01.LAB.0000106724.29121.DA","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia\/reperfusion injury in a rat model","volume":"83","author":"Ito","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/S1542-3565(04)00457-4_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","article-title":"ACRP30\/adiponectin","volume":"13","author":"Berg","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S1542-3565(04)00457-4_bib27","doi-asserted-by":"crossref","first-page":"41245","DOI":"10.1074\/jbc.M103241200","article-title":"The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance","volume":"276","author":"Yamauchi","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S1542-3565(04)00457-4_bib28","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/S1542-3565(04)00457-4_bib29","first-page":"G865","article-title":"Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription","volume":"281","author":"Clarke","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/S1542-3565(04)00457-4_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0026-0495(95)90270-8","article-title":"In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues","volume":"44","author":"Assimacopoulos-Jeannet","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/S1542-3565(04)00457-4_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1749-6632.1994.tb17336.x","article-title":"Pathophysiology and pathogenesis of visceral fat obesity","volume":"748","author":"Matsuzawa","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S1542-3565(04)00457-4_bib32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1051\/medsci\/20031989834","article-title":"Insulin signaling","volume":"19","author":"Capeau","year":"2003","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/S1542-3565(04)00457-4_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2003.08.020","article-title":"Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes","volume":"419","author":"Chavez","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/S1542-3565(04)00457-4_bib34","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/S1542-3565(04)00457-4_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2001-12929","article-title":"Mitochondria in steatohepatitis","volume":"21","author":"Pessayre","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/S1542-3565(04)00457-4_bib36","first-page":"G193","article-title":"Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis","volume":"282","author":"Pessayre","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/S1542-3565(04)00457-4_bib37","first-page":"751","article-title":"Antioxidant vitamins do not prevent cardiovascular disease","volume":"52","author":"Roychoudhury","year":"2003","journal-title":"J Fam Pract"},{"key":"10.1016\/S1542-3565(04)00457-4_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1022134418372","article-title":"Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials","volume":"16","author":"Clarke","year":"2002","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356504004574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356504004574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:53:04Z","timestamp":1761540784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356504004574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S1542356504004574"],"URL":"https:\/\/doi.org\/10.1016\/s1542-3565(04)00457-4","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1542-3565(04)00457-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Gastroenterological Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}